Modulation of gene expression and DNA-adduct formation in precision-cut liver slices exposed to polycyclic aromatic hydrocarbons of different carcinogenic potency

Mutagenesis

Volumn 22, Issue 1, 2007, Pages 55-62

  Staal, Yvonne C M ^a   Van Herwijnen, Marcel H M ^a   Pushparajah, Daphnee S ^b   Umachandran, Meera ^b   Ioannides, Costas ^b   Van Schooten, Frederik J ^a   Van Delft, Joost H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLPHENANTHRENE; BENZO[A]PYRENE; BENZO[B]FLUORANTHENE; DIBENZ[A,H]ANTHRACENE; DIBENZO[A,L]PYRENE; FLUORANTHENE; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARCINOGEN DNA INTERACTION; CARCINOGENICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ADDUCT; DNA DETERMINATION; DNA MICROARRAY; EXPOSURE; GENE EXPRESSION; GENE EXPRESSION PROFILING; ISOTOPE LABELING; LIVER CARCINOGENESIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE SLICE;

ANIMALS; CARCINOGENICITY TESTS; CLUSTER ANALYSIS; DISSECTION; DNA ADDUCTS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIVER; MALE; POLYCYCLIC HYDROCARBONS, AROMATIC; RATS; RATS, WISTAR;

EID: 33846085244     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gel058     Document Type: Article

References (41)

1. IARC (1973) Certain polycyclic aromatic hydrocarbons and heterocyclic compounds. IARC Monogr. Eval. Carcinog. Risk Chem. Hum., 3, 1-271.
2. IARC (1983) Polynuclear aromatic compounds, Part 1, Chemical, environmental and experimental data. IARC Monogr. Eval. Carcinog. Risk Chem. Hum., 32, 1-453.
3. Melendez-Colon,V.J., Luch,A., Seidel,A. and Baird,W.M. (2000) Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures. Chem. Res. Toxicol., 13, 10-17.
4. Xue,W. and Warshawsky,D. (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol. Appl. Pharmacol., 206, 73-93.
5. Ross,J.A., Nelson,G.B., Wilson,K.H., Rabinowitz,J.R., Galati,A., Stoner,G.D., Nesnow,S. and Mass,M.J. (1995) Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res., 55, 1039-1044.
6. Kriek,E., Rojas,M., Alexandrov,K. and Bartsch,H. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat Res., 400, 215-231.
7. Harrigan,J.A., Vezina,C.M., McGarrigle,B.P., Ersing,N., Box,H.C., Maccubbin,A.E. and Olson,J.R. (2004) DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo(a)pyrene. Toxicol Sci., 77, 307-314.
8. Arif,J.M., Smith,W.A. and Gupta,R.C. (1999) DNA adduct formation and persistence in rat tissues following exposure to the mammary carcinogen dibenzo[a,l]pyrene. Carcinogenesis, 20, 1147-1150.
9. Segerback,D. and Vodicka,P. (1993) Recoveries of DNA adducts of polycyclic aromatic hydrocarbons in the 32P-postlabelling assay. Carcinogenesis, 14, 2463-2469.
10. Shimada,T. and Fujii-Kuriyama,Y. (2004) Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci., 95, 1-6.
11. Shimada,T., Sugie,A., Shindo,M., Nakajima,T., Azuma,E., Hashimoto,M. and Inoue,K. (2003) Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol. Appl. Pharmacol., 187, 1-10.
12. Melendez-Colon,V.J., Luch,A., Seidel,A. and Baird,W.M. (1999) Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites. Carcinogenesis, 20, 1885-1891.
13. Machala,M., Vondracek,J., Blaha,L., Ciganek,M. and Neca,J.V. (2001) Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay. Mutat Res., 497, 49-62.
14. Solhaug,A., Refsnes,M., Lag,M., Schwarze,P.E., Husoy,T. and Holme,J.A. (2004) Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis, 25, 809-819.
15. Bostrom,C.E., Gerde,P., Hanberg,A., Jernstrom,B., Johansson,C., Kyrklund,T., Rannug,A., Tornqvist,M., Victorin,K. and Westerholm,R. (2002) Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ. Health Perspect., 110 (Suppl 3), 451-488.
16. Nisbet,I.C. and LaGoy,P.K. (1992) Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Regul. Toxicol. Pharmacol., 16, 290-300.
17. Collins,J.F., Brown,J.P., Alexeeff,G.V. and Salmon,A.G. (1998) Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Pharmacol., 28, 45-54.
18. Hu,T., Gibson,D.P., Carr,G.J., Torontali,S.M., Tiesman,J.P., Chaney,J.G. and Aardema,M.J. (2004) Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mutat. Res., 549, 5-27.
19. van Delft,J.H., van Agen,E., van Breda,S.G., Herwijnen,M.H., Staal,Y.C. and Kleinjans,J.C. (2004) Discrimination of genotoxic from nongenotoxic carcinogens by gene expression profiling. Carcinogenesis, 25, 1265-1276.
20. Parrish,A.R., Fisher,R., Bral,C.M., Burghardt,R.C., Gandolfi,A.J., Brendel,K. and Ramos,K.S. (1998) Benzo(a)pyrene-induced alterations in growth-related gene expression and signaling in precision-cut adult rat liver and kidney slices. Toxicol. Appl. Pharmacol., 152, 302-8.
21. Hashemi,E., Dobrota,M., Till,C. and Ioannides,C. (1999) Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures. Xenobiotica, 29, 11-25.
22. Staal,Y.C., van Herwijnen,M.H., van Schooten,F.J. and van Delft,J.H. (2005) Application of four dyes in gene expression analyses by microarrays. BMC Genomics, 6, 101.
23. Tibshirani,R., Hastie,T., Narasimhan,B. and Chu,G. (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl Acad. Sci. USA, 99, 6567-6572.
24. Doniger,S.W., Salomonis,N., Dahlquist,K.D., Vranizan,K., Lawlor,S.C. and Conklin,B.R. (2003) MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol., 4, R7.
25. Dahlquist,K.D., Salomonis,N., Vranizan,K., Lawlor,S.C. and Conklin,B.R. (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet., 31, 19-20.
26. Reddy,M.V. and Randerath,K. (1986) Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
27. Godschalk,R.W., Maas,L.M., Van Zandwijk,N., van't Veer,L.J., Breedijk,A., Borm,P.J., Verhaert,J., Kleinjans,J.C. and van Schooten,F.J. (1998) Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis, 19, 819-825.
28. Bardwell,L., Cook,J.G., Zhu-Shimoni,J.X., Voora,D. and Thorner,J. (1998) Differential regulation of transcription: repression by unactivated mitogen-activated protein kinase Kss1 requires the Dig1 and Dig2 proteins. Proc. Natl Acad. Sci. USA, 95, 15400-15405.
29. Knight,L.P., Primiano,T., Groopman,J.D., Kensler,T.W. and Sutter,T.R. (1999) cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis, 20, 1215-1223.
30. Spivack,S.D., Hurteau,G.J., Fasco,M.J. and Kaminsky,L.S. (2003) Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res., 9, 6002-6011.
31. Staal,Y.C., van Herwijnen,M.H., van Schooten,F.J. and van Delft,J.H. (2006) Modulation of gene expression and DNA adduct formation in HepG2 cells by polycyclic aromatic hydrocarbons with different carcinogenic potencies. Carcinogenesis, 27, 646-655.
32. Wu,S., Zhang,D., Zhang,Z.P., Soprano,D.R. and Soprano,K.J. (1998) Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid. Oncogene, 17, 2839-2849.
33. Letterio,J.J. (2005) Disruption of the TGF-beta pathway and modeling human cancer in mice. Mutat Res., 576, 120-131.
34. Lichtor,T. and Dohrmann,G.J. (1986) Respiratory patterns in human brain tumors. Neurosurgery, 19, 896-899.
35. Rao,K.N. (1995) The significance of the cholesterol biosynthetic pathway in cell growth and (review). Anticancer Res., 15, 309-314.
36. Bannasch,P., Klimek,F. and Mayer,D. (1997) Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J. Bioenerg. Biomembr., 29, 303-313.
37. Uno,S., Dalton,T.P., Dragin,N., Curran,C.P., Derkenne,S., Miller,M.L., Shertzer,H.G., Gonzalez,F.J. and Nebert,D.W. (2006) Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of totalbody burden and clearance rate. Mol. Pharmacol., 69, 1103-1114.
38. Fletcher,N., Wahlstrom,D., Lundberg,R., Nilsson,C.B., Nilsson,K.C., Stockling,K., Hellmold,H. and Hakansson,H. (2005) 2,3,7,8-Tetrachlorodibenzo-p- dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol. Appl. Pharmacol., 207, 1-24.
39. Moss,S.F. and Blaser,M.J. (2005) Mechanisms of disease: Inflammation and the origins of cancer. Nat. Clin. Pract. Oncol., 2, 90-97; and quiz 1 p. following 113.
40. Li,H., Chen,F., Yu,L., Liu,M., Chen,H., Zhang,Y. and Liu,X. (2002) Expression of inflammation related enzymes during experimental rat lung carcinogenesis. Zhonghua Zhong Liu Za Zhi, 24, 316-319.
41. Gao,Y., Zhang,Z., Jiang,Z.S., Fang,S.G., Sun,E.W., Wang,Y. and Chen,B.H. (2002) Dynamic changes of matrix metalloproteinases in rat liver during the development of diethylnitrosamine-induced hepatocarcinoma. Di Yi Jun Yi Da Xue Xue Bao, 22, 865-868.